Docetaxel-treated METTL1-KO tumour cells exhibited dysregulated autophagy, increased DNA damage and apoptosis, leading to a reduction in cells re-entering the cell cycle (Ki67+cells) compared to wild-type cells (Fig. 7C, D). Here, METTL1 is linked to neoplasm.